Personal Genome Diagnostics

PGDx, founded by Johns Hopkins researchers Luis Diaz and Victor Velculescu, builds genomic analysis pipelines that turn tumor sequencing into clinically actionable reports. Now part of Labcorp, the Baltimore company's ML-driven variant-calling and signature analysis remain a core part of its precision oncology stack.